How should I assess for Fournier's gangrene?

Assessment of Fournier's Gangrene

Fournier's gangrene is primarily a clinical diagnosis requiring immediate recognition through focused history, physical examination including digital rectal exam, and targeted laboratory testing, with CT imaging reserved for stable patients only when it will not delay surgical intervention. [@2,@3,@4,1]

Clinical Assessment

History and Physical Examination

Obtain a focused medical history and perform a complete physical examination, including mandatory digital rectal examination. [@2,@3,@4,1]

Key clinical features to identify:

• Pain intensity: Severe perineal, scrotal, or genital pain that is disproportionate to visible findings—this is a critical early sign [@9,@11@]
• Cutaneous findings: Erythema, swelling, purulent discharge, crepitus (subcutaneous emphysema), and patches of necrotic tissue with surrounding edema [@1,@9,1]
• Systemic signs: Fever and tachycardia are commonly present [@9,1]
• Disease spread patterns: Infection extends cranially to the abdominal wall and caudally to the legs along fascial planes; testicular involvement is rare due to separate blood supply [@1,@9,1]

Critical pitfall: Up to 40% of patients may initially lack cutaneous signs, risking diagnostic delay and progression to high-mortality disease 2. Pain out of proportion to examination findings should trigger high suspicion even without obvious skin changes.

Laboratory Investigations

In patients with signs of systemic infection or sepsis, obtain:

• Complete blood count [@2,@3,@4,@5@]
• Serum creatinine and electrolytes [@2,@3,@4,1]
• Inflammatory markers (C-reactive protein, procalcitonin) [@2,@3,@4,@5@]
• Blood gas analysis [@2,@3,@4,1]

Mandatory diabetes screening: Check serum glucose, hemoglobin A1c, and urine ketones to investigate undetected diabetes mellitus, as diabetes is present in 32-66% of cases and is most frequent among non-survivors [@2,@3,@4,@5,@11,@18@]

Blood cultures: Obtain cultures of blood and any abscess material [@1@]

Risk Stratification Scores

Use the Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) score for early diagnosis and Fournier's Gangrene Severity Index (FGSI) for prognosis and risk stratification. [@2,@3,@4,1]

Important limitations of LRINEC:

• Variable sensitivity (43.2-80%) and should not be used to rule out necrotizing soft tissue infection 1
• Not sensitive in immunocompromised patients 1
• Use only to confirm diagnosis when clinical suspicion is already high, not as a screening tool 1

FGSI interpretation:

• Score >9.5 predicts significantly higher mortality (sensitivity 87.5%, specificity 100%) 3
• Mortality rate is 100% with score >10 versus 6% with score ≤9 3
• Mean FGSI of 3.75 in survivors versus 12.63 in non-survivors 3

Alternative scores: Age-adjusted Charlson Comorbidity Index (ACCI) and surgical Apgar Score (sAPGAR) are equally effective and more easily calculated at bedside 4

Imaging Assessment

CT Scan Indications

In stable patients with suspected Fournier's gangrene, consider performing CT scan. [@2,@3,@4,@5,1]

CT findings to identify:

• Asymmetric fascial thickening [@1,@14,5]
• Subcutaneous emphysema (gas in soft tissue)—hallmark finding but not present in all cases [@1,@14,5]
• Soft tissue stranding [@14,5]
• Fluid collections and abscess formation [@14,5]
• Disease extent and source of infection [@14,5]

CT has 90% sensitivity and 93.3% specificity for necrotizing soft tissue infections and provides superior evaluation of disease extent compared to radiography or ultrasound. [@6,5]

Critical Imaging Caveats

Imaging must never delay surgical intervention. [@2,@3,@4,@5,1]

In patients with hemodynamic instability persisting after proper resuscitation, do not obtain CT imaging—proceed directly to surgery. [@2,@3,@4,@5,1]

Alternative imaging: Bedside point-of-care ultrasound can demonstrate scrotal skin thickening, soft tissue inflammation, collections/abscesses, subcutaneous gas, and paratesticular fluid when CT is unavailable or patient transport is unsafe 1

Prognostic Factors

Key negative prognostic indicators:

• Coagulation dysfunction—most significant impact on in-hospital mortality 6
• Multidrug-resistant bacterial infection—independently associated with high mortality 6
• Initial Sequential Organ Failure Assessment (SOFA) score—significantly higher in non-survivors 6
• Need for mechanical ventilation and blood transfusions 4
• Acute renal failure 4
• Older age with multiple comorbidities [@15,@18@]
• Colorectal source of infection [@14